Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?
J Res Pharm Pract
.
2015 Jan-Mar;4(1):1-3.
doi: 10.4103/2279-042X.150043.
Authors
Akram Ahmad
1
,
Muhammad Umair Khan
1
,
Isha Patel
2
Affiliations
1
Department of Clinical Pharmacy, UCSI University, Kuala Lumpur, Malaysia E-mail: akrampharma67@gmail.com.
2
Department of Biopharmaceutical Sciences, Shenandoah University, Winchester, USA.
PMID:
25710043
PMCID:
PMC4326966
DOI:
10.4103/2279-042X.150043
No abstract available